Home/Filings/4/0001123292-16-002337
4//SEC Filing

Recro Pharma, Inc. 4

Accession 0001123292-16-002337

CIK 0001588972operating

Filed

May 24, 8:00 PM ET

Accepted

May 25, 3:47 PM ET

Size

4.3 KB

Accession

0001123292-16-002337

Insider Transaction Report

Form 4
Period: 2016-05-23
Mack Randall
Senior VP, Development
Transactions
  • Purchase

    Common Stock

    2016-05-23$6.30/sh+2,000$12,6002,000 total

Issuer

Recro Pharma, Inc.

CIK 0001588972

Entity typeoperating
IncorporatedPA

Related Parties

1
  • filerCIK 0001588972

Filing Metadata

Form type
4
Filed
May 24, 8:00 PM ET
Accepted
May 25, 3:47 PM ET
Size
4.3 KB